SUMMARY A case is reported in which recurrent episodes of visual loss occurred over a period of 26 years in a patient with bilateral optic disc drusen. Visual field loss was associated with episodes of ischaemic optic neuropathy. The possible mechanism is discussed.
Optic disc drusen may be associated with arcuate scotomas, constriction of the peripheral visual field or rarely the loss of central vision. (Fig. 2) . It was concluded that the disc drusen When seen by us in December 1985 visual acuities were right 6/9, left counting fingers. Further constriction of the visual fields had occurred (Fig. 3) . Examination of the discs showed bilateral optic disc drusen (Fig. 4) .
Discussion
Optic disc drusen consist of calcified, laminated aggregates of extracellular material. Recent ultrastructural studies by Tso4 and Spencer9 have indicated that drusen form as a result of alterations in axoplasmic transport at the disc producing accumulations of axoplasmic material. The association between optic disc drusen and visual field defects is common. In a large study Lorentzen found field defects in 87% patients with drusen,b but it is rare for optic disc drusen to be associated with loss of central vision, and it has been argued that this occurrence should prompt further investigation for another cause. ' The mechanism by which optic disc drusen produce field loss is uncertain. The visual field defects do not correspond to the position of the drusen on the disc. arcuate field loss and segmental disc pallor. This has been noted in four patients with optic disc drusen. 8 The circulation of the disc with drusen may also be more vulnerable because the disc is small. Recently an association has been established between optic disc drusen and an abnormally small disc.9 It is well recognised that there is an increased likelihood of ischaemic optic neuropathy occurring in small discs. "' In our patient with optic disc drusen it is probable that the recurrent episodes of visual loss were due to periods of relative vascular insufficiency producing ischaemic optic neuropathy. The rationale for treatment with corticosteroids during each episode of visual loss was to reduce additional damage caused by neuronal swelling. " Firm evidence is lacking that this treatment improved visual function, but it is of interest that she still retained 6/9 vision in one eye despite numerous episodes of visual loss.
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